Cohen Veterans Bioscience and Wounded Warrior Project Collaborate on Blood Tests To Treat PTSD

It is estimated 500,000 of this generation of wounded veterans live with the symptoms of post-traumatic stress disorder (PTSD). Another 320,000 suffered a traumatic brain injury (TBI). There are few proven methods to diagnose and treat the signature wounds of the wars in Afghanistan and Iraq. Not every veteran living with these ailments responds the same to specific treatment.

To help, Wounded Warrior Project (WWP) is working with Cohen Veterans Bioscience (CVB) to identify and study biomarkers that could improve treatment options. A biomarker is a measurable substance indicative of a disease or infection. For veterans, a specific biomarker found in a blood sample can confirm a PTSD diagnosis and the potential to respond to treatment.

By studying these substances, researchers hope to better target PTSD treatment in veterans and other trauma survivors.

“We would love to cure PTSD and TBI one day,” said Mike Richardson, WWP vice president of mental health and independence services. “Until then, we will continue to target treatment and do what is best for the veterans we serve.”

As part of this support Wounded Warrior Project’s Warrior Care Network will be actively involved in the research into biomarkers testing wounded veterans and helping identify the most effective treatment options. Warrior Care Network is an innovative partnership with four top facilities focused on providing world-class mental health care to wounded veterans. While the treatment shows clinically proven results, more can still be done.

“We value Wounded Warrior Project’s collaboration and support to help advance a first generation of PTSD & TBI diagnostics,” said Magali Haas, MD, PhD, CVB’s CEO & President. “We need an all-hands approach to tackle this important scientific & clinical challenge.”

This collaboration can advance a roadmap for discovery, replication, and qualification of biomarkers an effort that can create solutions in years, not decades.

SOURCE: Wounded Warrior Project

About the Wounded Warrior Project (WWP)

Wounded Warrior Project (WWP) began in 2003 as a small, grassroots effort providing simple care and comfort items to the hospital bedsides of the first wounded service members returning home from the conflicts in Iraq and Afghanistan. As their post-service needs evolved, so have our programs and services. Today, through our direct programs in mental health, career counseling, and long-term rehabilitative care, along with our advocacy efforts, we improve the lives of millions of warriors and their families.

Share this article:

More from CVB

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

A Message from CEO Peter Hoehn

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

CVB President Nicole Harmon, PhD Discusses How Traumatic Brain Injury Has Impacted Her Family

https://www.cohenveteransbioscience.org/wp-content/uploads/2024/01/bibi-C-3.jpg

Interview with Bibi Carmouche, BASE Jumper for 22 Jumps Camelback Mountain 2024

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/03/cohen-veterans-bioscience-22-jumps.jpg

Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Crisis of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

For Media Inquiries

Please feel free to email us at media@cohenbio.org